findmyKOL
Clinical trialNCT00326417CompletedPhase 1/PHASE2Interventional

Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)

SponsorMedical College of WisconsinEnrollment97Anemia, Aplastic
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Mary Horowitz, MD

    Center for International Blood and Marrow Transplant Research

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Phoenix Children'S Hospital

    Phoenix, Arizona, United States

  • City of Hope National Medical Center

    Duarte, California, United States

  • Children'S Hospital Los Angeles

    Los Angeles, California, United States

  • Mattel Children'S Hospital at Ucla

    Los Angeles, California, United States

  • Stanford Hospital and Clinics

    Stanford, California, United States

  • H. Lee Moffitt Cancer Center

    Tampa, Florida, United States

  • Bmt Program at Northside Hospital

    Atlanta, Georgia, United States

  • Children'S Healthcare of Atlanta

    Atlanta, Georgia, United States

  • Dfci/brigham & Women'S Hospital

    Boston, Massachusetts, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

  • Roswell Park Cancer Institute

    Buffalo, New York, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • Cincinnati Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

  • Oregon Health & Science University

    Portland, Oregon, United States

  • Cook Children'S Medical Center

    Fort Worth, Texas, United States

  • University of Texas, Md Anderson Crc

    Houston, Texas, United States

  • Texas Transplant Institute

    San Antonio, Texas, United States

  • Virginia Commonwealth University, Mcv Hospital

    Richmond, Virginia, United States

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2006
Primary completion
30 Sept 2015
Completion
31 Jan 2016
Last update posted
28 Oct 2021
Registered enrollment
97
Registry id
NCT00326417

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.